Table of Contents Table of Contents
Previous Page  156 / 220 Next Page
Information
Show Menu
Previous Page 156 / 220 Next Page
Page Background

17. Potash AE, Karnell LH, Christensen AJ, Vander Weg MW, Funk GF. Con-

tinued alcohol use in patients with head and neck cancer.

Head Neck

2010;32:905–912.

18. Kugaya A, Akechi T, Okuyama T, et al. Prevalence, predictive factors, and

screening for psychologic distress in patients with newly diagnosed head

and neck cancer.

Cancer

2000;88:2817–2823.

19. Aarstad AK, Lode K, Larsen JP, Bru E, Aarstad HJ. Choice of psychologi-

cal coping in laryngectomized, head and neck squamous cell carcinoma

patients versus multiple sclerosis patients.

Eur Arch Otorhinolaryngol

2011;268:907–915.

20. Elani HW, Allison PJ. Coping and psychological distress among head and

neck cancer patients.

Support Care Cancer

2011;19:1735–1741.

21. Hammerlid E, Silander E, Hornestam L, Sullivan M. Health-related qual-

ity of life three years after diagnosis of head and neck cancer—a longitu-

dinal study.

Head Neck

2001;23:113–125.

22. de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst

JA. Long-term quality of life of patients with head and neck cancer.

Laryngoscope

2000;110:98–106.

23. Agarwal M, Hamilton JB, Crandell JL, Moore CE. Coping strategies of

African American head and neck cancer survivors.

J Psychosoc Oncol

2010;28:526–538.

24. Hammerlid E, Bjordal K, Ahlner-Elmqvist M, et al. A prospective study of

quality of life in head and neck cancer patients. Part I: at diagnosis.

Laryngoscope

2001;111:669–680

.

25. Bjordal K, Ahlner-Elmqvist M, Hammerlid E, et al. A prospective study of

quality of life in head and neck cancer patients. Part II: Longitudinal

data.

Laryngoscope

2001;111:1440–1452.

26. Terrell JE, Ronis DL, Fowler KE, et al. Clinical predictors of quality of life

in patients with head and neck cancer.

Arch Otolaryngol Head Neck

Surg

2004;130:401–408.

27. Abendstein H, Nordgren M, Boysen M, et al. Quality of life and head and

neck cancer: a 5 year prospective study.

Laryngoscope

2005;115:2183–

2192.

28. Hughes PJ, Scott PM, Kew J, et al. Dysphagia in treated nasopharyngeal

cancer.

Head Neck

2000;22:393–397.

29. Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xero-

stomia in patients with head and neck cancer: pathogenesis, impact on

quality of life, and management.

Head Neck

2004;26:796–807.

30. Jensen K, Jensen AB, Grau C. A cross sectional quality of life study of 116

recurrence free head and neck cancer patients. The first use of EORTC

H&N35 in Danish.

Acta Oncol

2006;45:28–37.

31. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR,

Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on

quality of life among patients with head and neck cancer treated with

radiotherapy.

J Clin Oncol

2008;26:3770–3776.

32. Reeve BB, Cai J, Zhang H, et al. Health-related quality of life differences

between African Americans and non-Hispanic whites with head and

neck cancer.

Head Neck

2013;35:1255–1264.

33. Divaris K, Olshan AF, Smith J, et al. Oral health and risk for head and

neck squamous cell carcinoma: the Carolina Head and Neck Cancer

Study.

Cancer Causes Control

2010;21:567–575.

34. D’Antonio LL, Zimmerman GJ, Cella DF, Long SA. Quality of life and

functional status measures in patients with head and neck cancer.

Arch

Otolaryngol Head Neck Surg

1996;122:482–487.

35. List MA, D’Antonio LL, Cella DF, et al. The Performance Status Scale for

Head and Neck Cancer Patients and the Functional Assessment of Can-

cer Therapy-Head and Neck Scale. A study of utility and validity.

Can-

cer

1996;77:2294–2301.

36. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer

Therapy scale: development and validation of the general measure.

J Clin Oncol

1993;11:570–579.

37. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness

Therapy (FACIT) Measurement System: properties, applications, and

interpretation.

Health Qual Life Outcomes

2003;1:79.

38. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to

explain the clinical significance of health status measures.

Mayo Clin

Proc

2002;77:371–383.

39. VanderWalde NA, Fleming M, Weiss J, Chera BS. Treatment of older

patients with head and neck cancer: a review.

Oncologist

2013;18:568–

578.

40. Fenn KM, Evans SB, McCorkle R, et al. Impact of financial burden of can-

cer on survivors’ quality of life.

J Oncol Pract

2014;10:332–338.

41. Rao D, Debb S, Blitz D, Choi SW, Cella D. Racial/Ethnic differences in the

health-related quality of life of cancer patients.

J Pain Symptom Man-

age

2008;36:488–496.

42. Utsey SO, Chae MH, Brown CF, Kelly D. Effect of ethnic group member-

ship on ethnic identity, race-related stress, and quality of life.

Cultur

Divers Ethnic Minor Psychol

2002;8:366–377.

43. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P.

Quality of life and oral function in patients treated with radiation ther-

apy for head and neck cancer.

Head Neck

2001;23:389–398.

44. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus

types in head and neck squamous cell carcinomas worldwide: a system-

atic review.

Cancer Epidemiol Biomarkers Prev

2005;14:467–475.

45. Penner JL. Psychosocial care of patients with head and neck cancer.

Semin Oncol Nurs

2009;25:231–241.

Reeve et al.: Factors Associated With Quality of Life

136